Stephen Hill
Chief Operating Officer chez LYELL IMMUNOPHARMA, INC.
Fortune : 19 909 $ au 31/03/2024
Profil
Stephen Hill is currently the Chief Operating Officer at Lyell Immunopharma, Inc. He previously worked as the Vice President-Bulk Manufacturing at Amgen, Inc. and as the SVP & Head-Global Biologics Operations at AstraZeneca PLC.
Mr. Hill received his undergraduate degree and MBA from the University of Washington.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LYELL IMMUNOPHARMA, INC.
0,00% | 09/02/2024 | 8 928 ( 0,00% ) | 19 909 $ | 31/03/2024 |
Postes actifs de Stephen Hill
| Sociétés | Poste | Début |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Chief Operating Officer | 01/11/2021 |
Anciens postes connus de Stephen Hill
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/06/2019 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formation de Stephen Hill
| University of Washington | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
